How long should Zidovudine prophylaxis be continued in the exposed newborn?

Enhance your readiness for the MEDNAX Neonatal Nurse Practitioner Exam. Utilize flashcards, multiple-choice questions, and detailed explanations. Equip yourself for success!

Multiple Choice

How long should Zidovudine prophylaxis be continued in the exposed newborn?

Explanation:
The main idea is protecting the newborn from HIV transmission by giving neonatal Zidovudine for a set period after birth. Zidovudine prophylaxis is started soon after birth to inhibit viral replication during the early period when exposure from the mother is most likely to lead to infection. Continuing the drug for six weeks provides sustained protection through the critical early weeks of life, balancing effectiveness with safety and practicality. Shorter durations, like one week, wouldn’t cover the whole high-risk window, while much longer courses aren’t routinely required and can add unnecessary exposure. Therefore six weeks is the recommended duration for Zidovudine prophylaxis in the HIV-exposed newborn.

The main idea is protecting the newborn from HIV transmission by giving neonatal Zidovudine for a set period after birth. Zidovudine prophylaxis is started soon after birth to inhibit viral replication during the early period when exposure from the mother is most likely to lead to infection. Continuing the drug for six weeks provides sustained protection through the critical early weeks of life, balancing effectiveness with safety and practicality. Shorter durations, like one week, wouldn’t cover the whole high-risk window, while much longer courses aren’t routinely required and can add unnecessary exposure. Therefore six weeks is the recommended duration for Zidovudine prophylaxis in the HIV-exposed newborn.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy